NCAN and ocular melanoma: Altogether, these results demonstrate that all OECs treated groups presented a reduction of GFAP (astrocyte reactivity) and neurocan (glial scar component) stainings in comparison to Md treated group and in particular Purified OM treated group displayed a significantly greater reduction of neurocan expression in comparison to all the other OECs treated groups.